Screener
Opko Health OPK Diagnostics — Goodwill
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| (In thousands) | 2026 / Grossgoodwill at January 1,2026 | 2026 / Cumulativeimpairmentat January 1 | 2026 / Foreignexchangeand other | 2026 / Balance at June 30, 2026 |
|---|---|---|---|---|
| OPKO Chile | 3,553 | — | (82) | 3,471 |
| OPKO Health Europe | 7,740 | — | (219) | 7,521 |
| OPKO Mexico | 100 | (100) | — | — |
| Transition Therapeutics | 3,421 | (3,421) | — | — |
| Diagnostics | ||||
| BioReference | 163,442 | — | — | 163,442 |
| OPKO Diagnostics | 17,977 | (17,977) | — | — |
| $522,312 | $(38,023) | $(2,774) | $481,515 |
Item 1. Financial Statements
FAQ
- What is Opko Health's diagnostics — goodwill?
- Opko Health (OPK) reported diagnostics — goodwill of $163.44M in Q2 2026.
- How has Opko Health's diagnostics — goodwill changed year-over-year?
- Opko Health's diagnostics — goodwill decreased by 0.0% year-over-year, from $163.44M to $163.44M.
- What is the long-term trend for Opko Health's diagnostics — goodwill?
- Over 4 years (2021 to 2025), Opko Health's diagnostics — goodwill has grown at a -19.9% compound annual growth rate (CAGR), from $1.59B to $653.77M.
- What does diagnostics — goodwill mean?
- Represents the net carrying value of goodwill allocated to the diagnostics business segment. This asset reflects the premium paid over the fair value of net identifiable assets during acquisitions within the diagnostics division. It serves as an indicator of the long-term value attributed to the segment's market position and intangible synergies.
Ask your AI about Opko Health's diagnostics — goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude